Literature DB >> 25498453

GVHD prophylaxis made safe, easy, and inexpensive.

Olle Ringdén1.   

Abstract

In this issue of Blood, Kanakry and coworkers report on the use of posttransplant cyclophosphamide (Cy) as sole immunoprophylaxis against graft-versus-host disease (GVHD) in HLA-matched related or unrelated allogeneic hematopoietic stem cell transplant (HSCT).

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25498453     DOI： 10.1182/blood-2014-10-607879

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  2 in total

Review 1.  A Review of Cyclophosphamide-Induced Transplantation Tolerance in Mice and Its Relationship With the HLA-Haploidentical Bone Marrow Transplantation/Post-Transplantation Cyclophosphamide Platform.

Authors:  Hisanori Mayumi
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

2.  A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation.

Authors:  Myung-Won Lee; Sang Hoon Yeon; Won-Hyoung Seo; Hyewon Ryu; Hyo-Jin Lee; Hwan-Jung Yun; Deog-Yeon Jo; Ik-Chan Song
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.